Neoadjuvant Toripalimab + Chemotherapy ± Cetuximab in Locally Advanced Head and Neck Squamous Cell Carcinoma (Neo-ICT)

NCT06647563 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

355

Enrollment

OTHER

Sponsor class

Conditions

Squamous Cell Carcinoma of Head and Neck

Interventions

BIOLOGICAL: Toripalimab
BIOLOGICAL: Cetuximab
DRUG: Albumin-Bound Paclitaxel
DRUG: Carboplatin
DRUG: Cisplatin
RADIATION: Radiotherapy 60 Gray/day
RADIATION: Radiotherapy 66 Gray/day
RADIATION: Radiotherapy 70 Gray/day

Sponsor

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University